1. Kamioka, Hiroshi, Yogosawa, Satomi, Oikawa, Tsunekazu, Saruta, Masayuki, Yoshida, Kiyotsugu. 2023. Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras. In JHEP reports : innovation in hepatology, 5, 100759. doi:10.1016/j.jhepr.2023.100759. https://pubmed.ncbi.nlm.nih.gov/37333975/
2. Wu, Chunrong, Sun, Guiyin, Wang, Fan, Quan, Jin, Xiang, Debing. 2022. DYRK2 downregulation in colorectal cancer leads to epithelial-mesenchymal transition induction and chemoresistance. In Scientific reports, 12, 22496. doi:10.1038/s41598-022-25053-0. https://pubmed.ncbi.nlm.nih.gov/36577753/
3. Park, Chun Shik, Lacorazza, H Daniel. 2020. DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells. In Experimental & molecular medicine, 52, 1663-1672. doi:10.1038/s12276-020-00515-5. https://pubmed.ncbi.nlm.nih.gov/33067577/
4. Wang, Yuchan, Wu, Yaxun, Miao, Xiaobing, Xu, Xiaohong, He, Song. 2015. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma. In International journal of biological macromolecules, 81, 809-17. doi:10.1016/j.ijbiomac.2015.08.067. https://pubmed.ncbi.nlm.nih.gov/26341817/
5. Sun, Wei, Jiao, Shuang, Tan, Xungang, Zhang, Peijun, You, Feng. . DYRK2 displays muscle fiber type specific function during zebrafish early somitogenesis. In The International journal of developmental biology, 61, 459-463. doi:10.1387/ijdb.160175sj. https://pubmed.ncbi.nlm.nih.gov/28695966/
智鼠故事 
